Therapeutics in Rheumatology
Published on 11. November 2013
XIV, 557 pages
978-1-4899-2883-2 (ISBN)
Description
This book is about the drugs used in the treatment and management of rheumatic disorders. The term 'therapeutics' used in the title is intended to mirror the relevance of drugs in the widest sense of the word. Thus, general principles underlying pharmaceutical and pharmacological study have been included together with more clinical matters concerned with applying specific rheumatic problems. The need for another work on rheumatological drugs in itself, as opposed to the different approach intended, was prompted by the ever continuing and bewildering plethora of antirheumatic drugs flooding the market at present. We believe that such a burgeoning of new preparations is welcome in an era when in general there are still no 'cures' available. Moreover, we also feel that a continued update of this rapidly advancing field is essential, not only for its own sake, but also to place it in perspective with itself and with neighbouring fields.
More details
Other editions
Additional editions
H. A. Bird | J. M. H. Moll | A. Rushton
Therapeutics in Rheumatology
Book
01/1986
Chapman and Hall
€53.49
Shipment within 10-20 days
Content
Section I Pharmacological and therapeutic principles.- 1. The pharmacological basis of antirheumatic drug therapy.- 2. Pharmacokinetics.- 3. Drug interactions.- 4. Adverse reactions.- 5. Evaluation of drug response.- Section II The rheumatological pharmacopoeia.- 6. Simple analgesics and pain.- 7. Non-steroidal anti-inflammatory drugs.- 8. Corticosteroids in rheumatic diseases.- 9. Slow-acting antirheumatoid drugs.- 10. New drugs and experimental progress.- Section III Clinical applications and implications.- 11. Rheumatoid arthritis.- 12. The spondarthritides.- 13. Osteoarthrosis, spinal degenerative disease and other back pain syndromes.- 14. Gout and other crystal-deposition disorders.- 15. Miscellanea and rarities.- 16. Drug-induced syndromes and drug toxicity.- International glossary of proprietary antirheumatic drugs.
